Skip to content
★ Sign in to follow
Nutra Pharma Corp logo

Nutra Pharma Corp Stock: price and insider trades · United States

No insider purchase over the last 90 days. The latest, by DEITSCH RIK J, was filed 26 Jun 2018.

Nutra Pharma Corp: what insiders have been doing

Nutra Pharma Corp, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SEC (Form 4). In the past year (24 October 2025 to 24 October 2026), 1 filing came from 1 insider.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

Insider buying of Nutra Pharma Corp has been absent for the past year.

Compared with its exchange (282 companies, median 8 filings), a count of 1 filing is below the norm. Looking back to 2008, when coverage begins, insiders filed 26 purchases and 2 sales.

This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Insider Decl.
49
Thresholds
n/a
Buy Volume
€197M
26 ops. · all time
Sell Volume
€118,220
2 ops. · all time

Since the insiders bought

  • Filed 21 Mar 2014 · 4615 days ago · €2,309
    -61.0%
    Entry US$0.28 · Close at T+365 US$0.11
  • Filed 21 Mar 2014 · 4615 days ago · €28k
    -61.0%
    Entry US$0.28 · Close at T+365 US$0.11
  • Filed 11 Sept 2012 · 5171 days ago · €48
    +6.7%
    Entry US$0.60 · Close at T+365 US$0.64

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Financial data

as of FY 2025

FY ended December 2025 · cache

US$0.00
Analyst consensus
·
Income statement
RevenueUS$385.3k
Gross profitUS$196.6k51% margin
EBITDA-US$1.5M-391% margin
Net income-US$2M-531.4% margin
Valuation
Beta59.20
Balance sheet & cash
Total debtUS$9.8M
Free Cash Flow-US$1.2M
Profitability & ownership
ROA-138.1%
% insiders1.0%
% institutions0.0%
Last declaration on 1 September 2026
Declarations49 total
  • ●
    10% OwnerExecutives
    0SEC
    12,000,000 shares0Series B Preferred StockSEC:0001493152-26-041002:0
  • ▲
    President, CEOExecutives
    100,000 USD0SEC
    1,250,000 shares@ US$0.08Nutra Pharma Corp Common StockSEC:0001387131-18-002844:0
    Canonical exit: 9 Jul 2014 (T+90)
  • ◆
    President, CEOExecutives
    121,656 USD0SEC
    506,900 shares@ US$0.24Nutra Pharma Corp Common StockSEC:0001387131-18-002844:1
  • ◆
    President, CEOExecutives
    740,000 USD0SEC
    4,000,000 shares@ US$0.185Nutra Pharma Corp Common StockSEC:0001387131-18-002844:2
  • ◆
    President, CEOExecutives
    54,000 USD0SEC
    4,000,000 shares@ US$0.0135Nutra Pharma Corp Common StockSEC:0001387131-18-002844:3
  • ▲
    President, CEOExecutives
    100,500 USD0SEC
    15,000,000 shares@ US$0.0067Nutra Pharma Corp Common StockSEC:0001387131-18-002844:4
    Canonical exit: 3 Oct 2016 (T+90)
  • ▲
    President, CEOExecutives
    75,000 USD0SEC
    15,000,000 shares@ US$0.005Nutra Pharma Corp Common StockSEC:0001387131-18-002844:5
    Canonical exit: 19 Mar 2017 (T+90)
  • ◆
    DirectorExecutives
    0SEC
    7,730,000 sharesNPHC Common StockSEC:0001144204-14-018923:0
  • ●
    DirectorExecutives
    560 USD0SEC
    70,000 shares@ US$0.008NPHC Common StockSEC:0001144204-14-018923:1
  • ◆
    DirectorExecutives
    47,438 USD0SEC
    2,875,000 shares@ US$0.0165Nutra Pharma CorpSEC:0001144204-14-017709:0
  • ◆
    DirectorExecutives
    121,000 USD0SEC
    5,500,000 shares@ US$0.022Nutra Pharma CorpSEC:0001144204-14-017709:1
  • ◆
    DirectorExecutives
    96,460 USD0SEC
    6,890,000 shares@ US$0.014Nutra Pharma CorpSEC:0001144204-14-017709:2
  • ◆
    President, CEOExecutives
    165,000 USD0SEC
    7,500,000 shares@ US$0.022Nutra Pharma CorpSEC:0001144204-14-017004:0
  • ▲
    President, CEOExecutives
    2,980 USD0SEC
    200,000 shares@ US$0.0149Nutra Pharma CorpSEC:0001144204-14-017004:1
    Canonical exit: 10 Mar 2013 (T+90)
  • ▲
    President, CEOExecutives
    100,000 USD0SEC
    10,000,000 shares@ US$0.01Nutra Pharma CorpSEC:0001144204-14-017004:2
    Canonical exit: 19 Mar 2013 (T+90)
  • ▲
    President, CEOExecutives
    100,000 USD0SEC
    25,000,000 shares@ US$0.004Nutra Pharma CorpSEC:0001144204-14-017004:3
    Canonical exit: 25 Sept 2013 (T+90)
  • ▲
    President, CEOExecutives
    62,500 USD0SEC
    25,000,000 shares@ US$0.0025Nutra Pharma CorpSEC:0001144204-14-017004:4
    Canonical exit: 8 Dec 2013 (T+90)
  • ◆
    President, CEOExecutives
    164,640 USD0SEC
    11,760,000 shares@ US$0.014Nutra Pharma CorpSEC:0001144204-14-017004:5
  • ▼
    President - ReceptoPharmExecutives
    156,000 USD0SEC
    400,000 shares@ US$0.39Nutra Pharma CorpSEC:0001144204-14-017035:0
  • ◆
    President - ReceptoPharmExecutives
    66,000 USD0SEC
    4,000,000 shares@ US$0.0165Nutra Pharma CorpSEC:0001144204-14-017035:1
  • ◆
    President - ReceptoPharmExecutives
    110,000 USD0SEC
    5,000,000 shares@ US$0.022Nutra Pharma CorpSEC:0001144204-14-017035:2
  • ▲
    President - ReceptoPharmExecutives
    37,000 USD0SEC
    14,800,000 shares@ US$0.0025Nutra Pharma CorpSEC:0001144204-14-017035:3
    Canonical exit: 8 Dec 2013 (T+90)
  • ◆
    President - ReceptoPharmExecutives
    103,600 USD0SEC
    7,400,000 shares@ US$0.014Nutra Pharma CorpSEC:0001144204-14-017035:4
  • ◆
    DirectorExecutives
    0SEC
    5,000,000 sharesNPHC Common StockSEC:0001144204-13-018044:0
  • ▲
    Executives
    63 USD0SEC
    5,000 shares@ US$0.0125Common StockSEC:0001144204-12-050640:0
    Canonical exit: 22 Jul 2012 (T+90)

25 of 49 declarations

About Nutra Pharma Corp

Nutra Pharma Corp is a company listed on the XNAS market, specializing in the development of pharmaceutical products and nutritional supplements. It focuses on solutions for health and wellness.